Fibrinolysis Inhibiting Factor 5 mg | ≥98% LKT Laboratories, Inc. Peptide; fibrinolysis inhibitor. More Information Supplier Page × Fibrinolysis Inhibiting Factor
Fibrinogen γ-chain Dodecapeptide 5 mg | ≥98% LKT Laboratories, Inc. Platelet substitute, peptide; GP IIb/IIIa activator. More Information Supplier Page × Fibrinogen γ-chain Dodecapeptide
Fibrinogen γ-chain Dodecapeptide 2 mg | ≥98% LKT Laboratories, Inc. Platelet substitute, peptide; GP IIb/IIIa activator. More Information Supplier Page × Fibrinogen γ-chain Dodecapeptide
Fibrinogen γ-chain Dodecapeptide 1 mg | ≥98% LKT Laboratories, Inc. Platelet substitute, peptide; GP IIb/IIIa activator. More Information Supplier Page × Fibrinogen γ-chain Dodecapeptide
Fibrinogen-binding Peptide 5 mg | ≥98% LKT Laboratories, Inc. GP IIb/IIIa analog, peptide; fibrinogen binding inhibitor. More Information Supplier Page × Fibrinogen-binding Peptide
Fasudil Hydrochloride 250 mg | ≥98% LKT Laboratories, Inc. ROCK inhibitor. More Information Supplier Page × Fasudil Hydrochloride
Fasudil Hydrochloride 100 mg | ≥98% LKT Laboratories, Inc. ROCK inhibitor. More Information Supplier Page × Fasudil Hydrochloride
Famotidine 5 g | ≥98% LKT Laboratories, Inc. Histamine H2 antagonist, GSK-3β inhibitor. More Information Supplier Page × Famotidine
Famotidine 1 g | ≥98% LKT Laboratories, Inc. Histamine H2 antagonist, GSK-3β inhibitor. More Information Supplier Page × Famotidine
Famotidine 500 mg | ≥98% LKT Laboratories, Inc. Histamine H2 antagonist, GSK-3β inhibitor. More Information Supplier Page × Famotidine
